Mahmoud Abunasser

6PUBLICATIONS
13CO-AUTHORS
Molecular targetsAged care nursingCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 04, 2024
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country.

Hikmat Abdel-Razeq, Baha Sharaf, Suhaib Khater

|Oct 04, 2023
Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan.

Mahmoud Abunasser, Hala Abu-Fares, Sarah Abdel-Razeq

|Mar 18, 2022
Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.

Hikmat Abdel-Razeq, Baha' Sharaf, Rama AlMasri

|Jan 13, 2022
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review.

Baha' Sharaf, Rama AlMasri, Nayef Abdel-Razeq

|Jun 17, 2021
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives.

Hikmat Abdel-Razeq, Faris Tamimi, Lama Abujamous

|Dec 11, 2019
Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing Country.

Hikmat Abdel-Razeq, Hanan Almasri, Fadwa Abdel Rahman

Pageof 1

Frequent Collaborators

6 joint publications

Hikmat Abdel-Razeq

3 joint publications

Baha' Sharaf

2 joint publications

Faris Tamimi

2 joint publications

Ayat Taqash